2022-23 Academic Calendar (PDF)
« All Events
Join us for this Industry Talk with Carol A. Nacy, Chief Executive Officer at Sequella, Inc.
Dr. Carol A. Nacy is a founder and the Chief Executive Officer of Sequella, Inc., a privately-held pharmaceutical company that discovers and develops new and more effective treatments for life-threatening infectious diseases.
Prior to Sequella, Nacy was Executive Vice President and Chief Scientific Officer at EntreMed, Inc., from 1993 through its successful public offering in June 1996. She left EntreMed in November 1996 to establish Sequella, Inc. and was part-time Chief Scientific Officer (1997-1998) for Anergen, Inc., a California company focused on autoimmune diseases. There, she reorganized the scientific staff and worked with the Management Team to position the company for acquisition by Corixa Corp. in December 1998.
Nacy has received several accolades for her leadership and entrepreneurship as a woman in science as well as her humanitarian work to create new drugs for TB.
Don’t miss this opportunity to learn from an experienced professional!
Click here to register to receive the Zoom log-in information.
Click here to see the rest of our upcoming events.
Celebrating 25 years of innovation! 25.kgi.edu.